A novel mutation of the MFN2 gene in a Chinese family with Charcot-Marie-Tooth disease

被引:2
|
作者
Wang, Y. W. [1 ]
Han, W. T. [1 ]
Jiang, M. [1 ]
Lu, C. X. [2 ,3 ,4 ]
Li, X. F. [1 ]
Zhang, X. [2 ,3 ,4 ]
Li, J. X. [1 ]
机构
[1] Key Lab Reprod Hlth Liaoning Prov, Shenyang, Huanggu, Peoples R China
[2] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China
[3] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China
[4] Peking Union Med Coll, Beijing 100021, Peoples R China
基金
中国国家自然科学基金;
关键词
Charcot-Marie-Tooth; Mitofusin; 2; Mutation; Gender; NEUROPATHY TYPE 2A; MITOFUSIN-2;
D O I
10.4238/2012.May.18.5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Charcot-Marie-Tooth (CMT) is a group of clinically and genetically heterogeneous inherited neuromuscular disorders. At present, more than 30 loci have been reported to be associated with CMT disease; point mutations in the mitofusin 2 (MFN2) gene is one of the most common causes. We studied a Chinese family with CMT disease in which the phenotype of affected individuals varied, and the weakness condition of the distal legs in males, except the proband, was less severe than in females in this family. Linkage analysis and PCR sequencing revealed a missense mutation (NM_014874.3: c.1066A>G) in the MFN2 gene, resulting in an animo acid substitution of threonine to alanine in condon 356 (Thr356Ala). This is a novel phenotype and mutation for CMT family.
引用
收藏
页码:1454 / 1459
页数:6
相关论文
共 50 条
  • [31] Diagnosis of Charcot-Marie-Tooth Disease
    Banchs, Isabel
    Casasnovas, Carlos
    Alberti, Antonia
    De Jorge, Laura
    Povedano, Monica
    Montero, Jordi
    Antonio Martinez-Matos, Juan
    Volpini, Victor
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2009,
  • [32] Update on Charcot-Marie-Tooth Disease
    Ágnes Patzkó
    Michael E. Shy
    Current Neurology and Neuroscience Reports, 2011, 11 : 78 - 88
  • [33] Pediatric Charcot-Marie-Tooth Disease
    Jani-Acsadi, Agnes
    Ounpuu, Sylvia
    Pierz, Kristan
    Acsadi, Gyula
    PEDIATRIC CLINICS OF NORTH AMERICA, 2015, 62 (03) : 767 - +
  • [34] Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease
    Pisciotta, Chiara
    Pareyson, Davide
    NEUROMUSCULAR DISORDERS, 2023, 33 (08) : 627 - 635
  • [35] Update on Charcot-Marie-Tooth Disease
    Patzko, Agnes
    Shy, Michael E.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (01) : 78 - 88
  • [36] Depression and Charcot-Marie-Tooth disease
    P. Vinci
    P. Gargiulo
    G. B. Colazza
    P. Vinci
    L. Padua
    C. Pazzaglia
    Neurological Sciences, 2007, 28 : 295 - 296
  • [37] Depression and Charcot-Marie-Tooth disease
    Vinci, P.
    Gargiulo, P.
    Colazza, G. B.
    NEUROLOGICAL SCIENCES, 2007, 28 (05) : 295 - 296
  • [38] Charcot-Marie-Tooth disease: an update
    Shy, ME
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (05) : 579 - 585
  • [39] MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families
    Braathen, Geir J.
    Sand, Jette C.
    Lobato, Ana
    Hoyer, Helle
    Russell, Michael B.
    BMC MEDICAL GENETICS, 2010, 11
  • [40] Connexin 32 mutation in a Turkish family with X-linked Charcot-Marie-Tooth disease
    Sahin, N
    Tan, M
    Kalay, E
    Calapoglu, M
    Karaguzel, A
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2003, 113 (06) : 777 - 785